Virbac will enter the fast-growing poultry vaccines segment in India
09 October 2023 - 10:18PM
Virbac will enter the fast-growing poultry vaccines segment in
India
Virbac announces the signing of an
agreement to acquire Globion, a leading Indian poultry vaccines
specialist. This transaction will bolster our position of animal
health market leader in India by extending Virbac India’s existing
poultry portfolio to the growing segment of avian
vaccines.
Founded in 2005, as a joint venture between
Suguna Group, one of the leading Indian poultry conglomerates, and
Lohmann Animal Health, a German poultry vaccines specialist,
Globion has developed robust know-how and expertise in the
development, manufacturing and commercialization of live and
inactivated vaccines targeting a large array of avian
pathogens.
Globion is based in Hyderabad where its
industrial and R&D facilities employ around 120 full-time
employees and generate approximately €12 million of annual revenue
and is independently run by a professional team.
Sébastien Huron, chief executive officer, Virbac
group said “We are extremely pleased and honored to welcome the
Globion team within our Virbac family. This acquisition illustrates
our 2030 Virbac vision and ambition to grow through “programmatic”
M&A investing in vaccines, a key strategic axis of development,
reinforcing our leadership position in India, the world’s most
populous country, and completing our portfolio targeting the
dynamic and promising poultry market. We will fully engage with the
Globion teams and provide them with additional resources to help
them perform at their best. We are united with the Suguna and
Globion teams by the common ambition to create long-term value for
our customers and build, through innovation, a competitive
portfolio of products to support the poultry industry in India and
abroad.”
B.Soundararajan, founder and managing director,
Suguna Group said “We started Globion primarily as a source of High
Quality Affordable Poultry Vaccines for Suguna Foods. In the last
ten years, Globion has rapidly transformed into a fast-growing
poultry biologicals company crossing 1 billion rupees of revenues
by consistently gaining market share in India & export markets.
By associating with a strategic partner having long term vision,
infrastructure and deep understanding of animal health in Indian
and global markets, we see immense potential for Globion to reach
greater heights. Virbac comes out as the right choice for us since
Virbac and Suguna share a common vision of adding value to the
poultry industry and Virbac’s acquisition of Globion is a
significant step in that direction. We will continue to remain a
key customer of Globion/Virbac in the future and our best wishes to
both Globion/Virbac teams for continued success.”
Veda Corporate Advisors were the advisors to
Suguna and Globion in this transaction.
Always working for animal
healthAt Virbac, we provide innovative solutions to
veterinarians, breeders and animal owners in more than 100
countries around the world. Covering more than 50 species, our
range of products and services makes it possible to diagnose,
prevent and treat the majority of pathologies. Every day, we are
committed to improving the quality of life of animals and together
shaping the future of animal health.
Press contact - Libre Mullenlowe
Agency
Camille Guaine –
c.guaine@libremullenlowe.fr – +33 7 60 54
00 39 |
- Press release_Virbac_Globion_October 9 2023
Virbac (EU:VIRP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Virbac (EU:VIRP)
Historical Stock Chart
From Jul 2023 to Jul 2024